Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
about
Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible CrosstalkAnalysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas.Linking proteomic and transcriptional data through the interactome and epigenome reveals a map of oncogene-induced signaling.The niche factor syndecan-1 regulates the maintenance and proliferation of neural progenitor cells during mammalian cortical developmentThermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaExpression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomasDysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1.A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells.A graphic method for identification of novel glioma related genes.Wnt activation promotes neuronal differentiation of glioblastomaThe Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres.STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancer.MicroRNA roles in beta-catenin pathway.Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinaseAflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a.Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression.Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line.Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factorSensitization of glioma cells to tamoxifen-induced apoptosis by Pl3-kinase inhibitor through the GSK-3β/β-catenin signaling pathwayDishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.Therapeutic potential of AZD1480 for the treatment of human glioblastomaInhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant gliomaMicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.FoxM1 and Wnt/β-catenin signaling in glioma stem cells.MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a.Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instabilityPGF(2alpha) stimulates FP prostanoid receptor mediated crosstalk between Ras/Raf signaling and Tcf transcriptional activation.Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancerCurcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway.
P2860
Q26865911-3F772637-9B7D-474E-B128-33384997DF32Q30366162-ADD68D4F-8A1B-4AAC-9397-A7420DBFA96AQ30424372-78406122-69A3-4B85-97F9-03EACCEC1EC6Q30588679-968B4DCB-BF02-4145-88DB-174DB1EA9387Q31088269-7D3007C6-4661-4E45-9DF8-CE705F98D97FQ33748280-8AAC9552-7F40-4BBF-8A1D-5BEC329E2FA0Q33777301-0F074419-D83D-4FA7-80BF-C3672D6F920EQ33792688-30FA75E3-3279-43AD-A4CE-AE835656C151Q33859439-6928B90C-5C8C-4F54-BA26-D2A8F65BCB1BQ33891391-D6B23A46-614D-4CA5-B6FF-12B3BC632E85Q33891429-45872EE2-E3D5-454E-8293-F529E0110B79Q33903166-8946607C-E5C3-494C-8D00-6675915BAA3EQ34075159-2A31FEFA-42F8-4421-A8B1-3934CCEA445EQ34104215-347B9593-89DA-4CB4-BFEC-7DDDC0F5F17FQ34202840-BC777AD8-6DE2-4761-9EC0-5BB03B0B59EDQ34205345-E21E86FC-AAA4-4678-ABCA-9DD9A2AD3122Q34456446-2C29B2A0-930C-4D7F-9ACC-EBE727458983Q34631652-96B001C3-C4E6-4FE6-A46C-3F3A7A970532Q34981651-F3077AF9-94F0-455B-8823-02DFE24BEDEBQ35011051-08A59E86-53A4-4451-8932-DD700792C17FQ35021344-8928EDFE-87A3-4E11-9E7B-BDA3B268D086Q35125619-048124EB-F648-450E-9142-8273E9BD08D1Q35234273-A879D36F-1BA8-43EF-BE87-B78DF9CAE994Q35463008-485AD77A-A857-4DEC-943A-B07FDD38433CQ35587229-EA862A62-51D5-4701-B4A6-AA99A4DDBDF7Q35613323-E13B68C4-05EA-4C2B-91BC-E43B17A15CB1Q35679531-94AD97E5-7D2A-4E03-9E3B-41D76ED557BEQ35780214-7B3D26DE-9F6E-44E0-8B4F-7F6535D62A51Q36139783-02543ADB-5E7F-4D2A-95FD-D7E43DA09EF8Q36405760-AC9A0457-C9BC-4EFC-B423-665536CE9637Q36546491-CBA234B7-5B98-4FDA-9CBB-BA1DD61EB03DQ37001237-FF500223-5CD2-4C07-92D8-2084BC1419B0Q37148194-97C1FC34-7E11-4B7F-B62F-18BF6A27F0E7Q37302306-F748879B-7EC8-40F8-941A-E8670F71005EQ37325934-D301D628-03B7-4AC0-B63F-5F1901886951Q37456232-E343B3C4-F54A-4B45-9ADD-DF0E925C9B0DQ37492137-32F94F4B-151A-48C6-A303-A10150BE5950Q37492161-6251CA94-8784-47AF-A488-BEDA80F95B83Q37589190-BABAA980-EC5C-4DB0-BF6B-716F14736B2BQ37595865-56546599-F196-4E6A-88B6-C147FE88727D
P2860
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@ast
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@en
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@nl
type
label
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@ast
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@en
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@nl
prefLabel
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@ast
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@en
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@nl
P2093
P2860
P356
P1433
P1476
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2008.78
P577
2008-10-24T00:00:00Z